chrisvoncsefalvay/vaers-outcomes huggingface dataset:
13 days later she had hives and redness and severe itching over site of vaccination. lasted about few hours. resolved in a day
Patient presented 15 minutes after administration of Varicella vaccine on 9/19/07 at 12:30 pm. With wheezing, eyelid swelling and confused Txed with 0.25 cc of Epinephrine 1:1000 -> Improved
A lot of bleeding at time of immunization and black and blue bruising that has lasted for more than 7 days.   The patient will follow-up with her primary doctor.
Information has been received from a physician concerning her 17-year-old son with a penicillin allergy and no other pertinent medical history who in May 2007 was vaccinated with a 5 mcg dose of Recombivax HB (lot# 654436/1106F).  Concomitant vaccination included a dose of diphtheria tetanus booster given on the same day as Recombivax HB.  Within 24 hours of vaccination, in May 2007, the patient experienced a fever of 102 F or 103 F and some myalgia.  Unspecified medical attention was sought but no laboratory or diagnostic tests were performed.  It was reported that the patient recovered within 2 or 3 days after the reaction.  No product quality complaint was involved.  Additional information has been requested.
had the shot an still got a mild case of shingles afterwards/ suspected vaccination failure; shingles; Very painful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was self-reported by the patient. The age at vaccination was not reported. The reporter stated that, he/she had the Shingles shot and still got a mild case of shingles afterwards. They were very painful.  The reporter also stated that, he/she would never get that shot again. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
9/26- could not sleep much at night, very cold. 9/27 (24 hrs after)- difficulty breathing, tachycardia, very dizzy and weak in the legs and whole body. Felt sick. Vomitting occurred 9/28- Headache, muscle aches, tired and cold all day. Not very hungry. Right eye (which is blind- previous condition) has hurt when putting in drops since vaccination.
Within minutes, left side of face became hot. Soon after, whole face hot, red, puffy. Eyes itchy. Sent to Occ Health and the ER. Given 2 BENADRYL, 2 prednisone, ZANTAC.
Tuesday I started having a runny nose that felt like allergies. In the evening I started having chills, after falling asleep I woke up with a 102 fever and my asthma was causing me trouble. I took my inhaler as needed for that. The fever came and went for about 30 hours. It would break and then I took an Advil then it would come back and went up to 103.5 as the highest reading. It did that from Tues 10pm to Wed around 1 am when it finally broke; Thursday I didn't have any fever. I went to the doctor with runny nose and a lot of chest congestion. I took a at home COVID-19 test that was negative. I went for a PCR test, results are coming in today. My asthma was getting really bad, worse attack I've had in years. I've been with a wet cough since Tuesday.
It was reported that a infant rec'd vaccines on 9/20/99. Pt was crying and developed a low grade fever on day of vaccination.
Our clinic did not give this vaccine.  I am reporting suspected vaccine reaction.  She states after Having the vaccine in April when she started her menstrual period in May.  She states she felt the blood coming out and started for the bathroom but before she could get there she had blood soaked through her clothes and pouring onto the floor.  She placed a super tampon, and a large pad and was soaking through these every 10-15 min.  after about 45 min the bleeding stopped as quickly as it had started.  She mentioned this to some of her female co-workers.  Several of them reported similar but less dramatic symptoms. They had all had the same Moderna covid-19 vaccine as it was provided by the employing company.
pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product was not provided. Treatment medication was not reported.; Reporter's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
This case was reported by a physician via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 8-year-old female patient who received KINRIX (batch number T325H, expiry date 17th February 2017). On 23rd August 2015, the patient received KINRIX. On 23rd August 2015, an unknown time after receiving KINRIX, the patient experienced inappropriate age at vaccine administration. On 25th August 2015, the patient experienced extensive swelling of vaccinated limb and injection site redness. The patient was treated with BENADRYL. On an unknown date, the outcome of the extensive swelling of vaccinated limb and injection site redness were recovered/resolved and the outcome of the inappropriate age at vaccine administration was unknown. The reporter considered the extensive swelling of vaccinated limb and injection site redness to be almost certainly related to KINRIX. Additional details were provided as follows: The patient received KINRIX at the age of 8 years, which led to an inappropriate age at vaccination. On 25th August 2015, 2 days after receiving KINRIX, the patient returned to the office with a 9 x 12 cm red and swollen area over the injection site. The patient was a healthy child and at the time of reporting, she was not on any medication except after the injection site reaction. No other information was reported.
Shot administered at 10:30 am on 6/11/2004. Reaction started at 3pm: crying when up. Tylenol given wit relief. Spitting up breast feeding and frequent stools the next day. 6/13/04: feeling better.
The day after the vaccination 11/13) I felt chills all day and was very sleepy and tired. On Sunday (11/14) I felt better. On Monday (11/15) I bled vaginally, I called the doctor and the appointment was given a week later so I went to the Emergency Department on Thursday (11/18), they checked me, they did an ultrasound and I got a Polyp and They recommended that I go to the Gynecologist. Blood until Wednesday (11/24) of the following week but less. Blood for 10 days. Little by little the bleeding decreased. On Monday, the Dr. did a Biopsy and the Biopsy came out normal. Four months after the 2nd vaccination I felt my breasts swollen, I went to the Gynecologist, but everything went normal, it lasted 2 weeks.
Hepatitis A #1 given 5/08, Hepatitis A #2 given 6/26/08. Pt. has been informed that they need to have the Hep A #2 vaccine given again in Dec, 08.
Delayed onset of subsequent menstruation followed by intense mood disruption, insomnia, debilitating unusually intense cramps for 4 hours (treated with ibuprofen) followed by early cessation of period and immediate resumption of PMS, specifically debilitating unusually intense cramps for 12 hours (ongoing, not fully redressed by ibuprofen)
Patient received her second Moderna COVID-19 vaccination today and approximately 20 minutes later felt her throat tightening up and her voice became raspy. She received IM epinephrine at around 11:45 am and was then sent to the emergency department. She states that the tightness in her throat has now resolved but her voice is still raspy. She also notes that she had some warm sensation across her chest that has now resolved. She is feeling itchy on the inside but denies any rash. She denies any tongue or lip swelling and denies any shortness of breath.
After the first injection the same night around 11pm I had extreme nausea and diarrhea that lasted through the night.  After the second injection my side effects were more extreme. That same night around 10pm I had drowsiness, so I went to bed. Shortly after I had nausea and chills. The chill were causing my body to shake severely even though I was covered in blankets. Then the body pain kicked in. It was so bad I couldn?t even walk, and just switching positions in bed brought me to tears.  In the morning I was running a fever of 100.2 and the body aches remained. My fever lasted 48hrs as well as the body aches. Overall, I felt so bad I contemplated going to the hospital.
pt recv vax & T101;child had a sz;pt admitted to hosp for 1wk;mom reported child suffered 2 more sz as of 16NOV98;
Pt c/o headache, 2/10,"funny feeling" 15 mins after receiving vaccine. He noted that he was hx of multiple allergies including anaphylaxis and sees allergist and gets allergy shots. He also noted that he has IDDM, has insulin pump. Self monitored.
Information has been received from a physician and a practice manager via company representatives referring to a patient of unknown age and gender. On 09-FEB-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB, 5 microgram/0.5 ml injection, thimerosal free (TF), lot # L014418, expiration date 13-APR-2017 (dose and route unspecified). This specified lot number vaccine was exposed to temperature excursion two times. The storage criteria and the type of excursion (R/F) were refrigerator (R). The lowest recorded temperature (Fahrenheit degree (F)) and total cumulative excursion time (hour) for the first time excursion was 34 F for 40 hours. The highest recorded temperature (F) and total cumulative excursion time (hour) for the second time excursion was 49 F for 16 hours. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
arm tenderness, pain and warmth.  swollen lymph nodes on left side of the neck along with tenderness in that area. pain in shoulder and scapula area on left side{side where injection was}.  all over body aches, headache, ear ache, chills, fever and diarrhea.  the very first symptoms were injection site pain and the swollen lymph nodes with in an hour of injection. headache and ear ache come on about 6hrs after followed shortly by diarrhea. the following day began chill and all over body ache along with previous symptoms. diarrhea had subsided by then. fever did not spike until nearly 24hrs later but only lasted a few hours. by the 48hr mark. symptoms have lessened but not completely gone. arm, neck shoulder pain remains the same as well as the swollen lymph nodes.
From an initial report received on 12/27/00, it was reported a 61 year old female was given YF-VAX, Hepatitis A, hepatitis B and Typhim VI vaccines on 11/29/00. Patient reportedly experienced "within 24 hours, injection site red and swollen, also developed lesions - looked like chicken pox over left clavicle, also a few on both arms and legs Was not seen by a physician. Lasted  3 weeks.
yeast infection; pressure in the right ear with throbbing; blood pressure was measured at 208 over 200 something; like you took a vacuum cleaner hose, opened my mouth, and turned my vacuum on. It sucked every ounce of fluid out of my body; thrush; dry mouth; raunchiest, smelliest bowel movements; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DRY MOUTH (like you took a vacuum cleaner hose, opened my mouth, and turned my vacuum on. It sucked every ounce of fluid out of my body), CANDIDA INFECTION (thrush), DRY MOUTH (dry mouth), MALABSORPTION (raunchiest, smelliest bowel movements) and FUNGAL INFECTION (yeast infection) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypertension. Concomitant products included AMLODIPINE for Blood pressure high.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced DRY MOUTH (like you took a vacuum cleaner hose, opened my mouth, and turned my vacuum on. It sucked every ounce of fluid out of my body), CANDIDA INFECTION (thrush), DRY MOUTH (dry mouth) and MALABSORPTION (raunchiest, smelliest bowel movements). On an unknown date, the patient experienced FUNGAL INFECTION (yeast infection), EAR DISCOMFORT (pressure in the right ear with throbbing) and HYPERTENSION (blood pressure was measured at 208 over 200 something). At the time of the report, DRY MOUTH (like you took a vacuum cleaner hose, opened my mouth, and turned my vacuum on. It sucked every ounce of fluid out of my body), CANDIDA INFECTION (thrush), DRY MOUTH (dry mouth), MALABSORPTION (raunchiest, smelliest bowel movements), FUNGAL INFECTION (yeast infection), EAR DISCOMFORT (pressure in the right ear with throbbing) and HYPERTENSION (blood pressure was measured at 208 over 200 something) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Blood pressure measurement: 208/200 High. In 2021, Blood pressure measurement: 140/85 normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications used were: Imodium for bowel movements, Ibuprofen for blood pressure,Terbinafine (powder) and Oral medication for yeast infection, gold bond powder for external yeast infection
This spontaneous report was received from a physician via a company representative concerning a male patient of unknown age. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot number, expiry date, dose unspecified) intramuscularly. No concomitant medications were reported. On an unknown date, while on PNEUMOVAX 23, the patient experienced unspecified reaction at the injection site and fever. He sought an unspecified medical attention. The outcome of unspecified reaction at the injection site and fever was reported as resolving on therapy. The relatedness for unspecified reaction at the injection site and fever was unknown for PNEUMOVAX. Additional information has been requested.
Bilateral inflammation, lower legs with red/purple petechial rash, resolved without treatment in 4 days. Recurred without obvious trigger Jun 26, resolved in 48 hours.  First and second dose and first booster were purple top, 2nd booster was grey top, all Pfizer  Photos  available.
patient came in for vaccines, consent form was handed to immunizer with Shingles and Flu HD written on consent form, immunizer administered both vaccines, after administration patient mentioned that they received flu shot a month prior, no adverse reaction reported on site
Light chest tightness; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Light chest tightness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (Light chest tightness). At the time of the report, CHEST DISCOMFORT (Light chest tightness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Client had a loss of  consciousness for 2-3 seconds while waiting in observation area after receiving vaccine. Reported feeling "tightness in jaw" just prior to LOC. Moved via wheelchair to EMS care on clinic site, placed in supine position on cot. 0940-BP-118/71. Reported h/o "passing out after vaccines". Felt fine within a few minutes and departed clinic accompanied by his wife after 30minutes.
Experienced the expected headache, high fever, chills, soreness for more than twelve hours starting at 4 am, 12 hours after receiving the vaccine. IN ADDITION I experienced a severe endometriosis flare up. I have been on both the birth control pill and the Mirena IUD to control my endometriosis symptoms and had not experienced a flare up in over a year, which is how I know it was connected to the vaccine. The symptoms of my flare up were severe abdominal pain and pelvic cramps, along with back pain radiating from my shoulders down my legs. The pain could not be controlled by over the counter medication, heat, ice, or any other usual methods. The worst of the flare up lasted exactly as long as the expected side effects, though I did have residual cramping a day or two afterward.
Vertigo: started approx 6 hours after dose, along with fatigue, bone, muscle aches. Initially Vertigo was with any head movement, feeling unstable on feet ,heavy feeling in head, feeling of nystagmus . Vertigo has improved but still persisting 2 weeks later, especially with change of position, especially lying down or getting up, instability is present but improved from initial stage.  Since vertigo started after vaccine, is persisting, think it is directly related to vaccination. Was fine before vaccine.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a female patient who received SHINGRIX for prophylaxis. The patient's past medical history included open heart surgery and arm operation. Previously administered products included Shingles vaccine (received in July 2010). On 18th July 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: For tolerance to further doses, refer case US2019GSK065334 (2nd dose). This case has been linked with the case US2019025070, (pharma case) reported by the same reporter and same patient.
At 2:35 PM pt had lower back pain and increased thirst for 10-15 min following IM FLUZONE HD. After event pt was anxious and had friend take him to ER. He was observed and released. At 9PM pt woke up diaphoretic went to ER was observed and released.
Patient was nervous/diaphoretic upon arrival to vaccine appointment. Patient received vaccine, was brought to observation area and seated, and within one minute patient lost consciousness and fell to ground from seated position. Patient was log rolled and opened his eyes and responded to name calling immediately after fall. V/S were taken, loaded onto stretcher. MD took HR, was in 40s. Initial full set of vitals 09:10 BP 115/70, HR 66, o2sat  99%.  Laid reverse trendelenburg in stretched. Physician on site and EMS was immediately called. Patient was diaphoretic and responsive/speaking. 09:13 121/55, HR 62, O2sat 98%. 09:17 120/57, HR 78, O2sat 98%, 09:25 118/68, HR 69, O2Sat 96%. At 9:31 patient left for ED with EMS.  Of note, patient reported after the fact that he has history of nervousness/anxiety with needles.
Within 4 hours developed cephalgia, myalgias, fatigue, nausea, chills and fever that spiked to 102 deg. 24 hours later still fatigued, but afebrile.
Right arm swelling, redness and itching started on the same night of the vaccine administration. Vaccine was administered on right deltoid.
The shot was given at 2:30pm, within 5 minutes I started experiencing chest tightness and very acute pain, much less sever than after the first shot. The tightness and discomfort lasted less than 10 minutes and subsided and did not return.
On 01/22/03, as part of 18 month check-up, child received DTaP#4, MMR#1, and IPV#3. (Immunization delayed) On 01/24/2003 right thigh was red and swollen. Temp 100.2F. Pt was instructed to give pt Tylenol, warm compresses, and Duricef X 10 days  p.o. On 01/28/2003 Pt rechecked, redness resolved, no fever, active but cries at night.  Pt instructed to continue Duricef and Motrin.
leaked out around the needle onto patient skin; leaked out around the needle onto patient skin; unsure how much dose patient received; This case was reported by a pharmacist via call center representative and described the occurrence of exposure via skin contact in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number 44T97, expiry date 18th September 2023) for prophylaxis.   On 23rd September 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 23rd September 2022, unknown after receiving Shingrix, the patient experienced exposure via skin contact, inadvertent exposure to vaccine and incomplete dose administered. On an unknown date, the outcome of the exposure via skin contact, inadvertent exposure to vaccine and incomplete dose administered were unknown.     Additional Information: GSK Receipt Date: 23-SEP-2022 Reporter's Comments: The registered pharmacist reported that the patient received first dose of Shingrix into left arm and reported that all operations were performed appropriately during reconstitution. The reporter stated that halfway through administration the medicine leaked out around the needle onto patient skin. PQC (product quality complaint) ruled out.  The reporter was unsure how much of a dose the patient received (thought about half). Education provided per package insert and content. The reporter did not consent to follow up. Additional Supportive Information: The reporter stated that halfway through administration the medicine leaked out around the needle onto patient skin and reporter was unsure how much of a dose the patient received, which led to inadvertent exposure to vaccine, exposure via skin contact and incomplete dose administered.